JFG
LXRX icon

Jefferies Financial Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Jefferies Financial Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Sell
68,734
-23,796
-26% -$34.6K ﹤0.01% 1590
2025
Q4 		$106K Sell
92,530
-4,870
-5% -$6.69K ﹤0.01% 1696
2025
Q3 		$131K Buy
+97,400
New +$111K ﹤0.01% 1319

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jefferies Financial Group's LXRX Position: Q1 2026 in Review

Jefferies Financial Group reduced its Lexicon Pharmaceuticals (LXRX) stake by 26% in Q1 2026, selling an estimated $34.6K and leaving 68,734 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

Jefferies Financial Group first reported a position in LXRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $131K in Q3 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Jefferies Financial Group held 68,734 shares of Lexicon Pharmaceuticals worth $107K as of Q1 2026.
  • Jefferies Financial Group sold 23,796 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $34.6K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1590 holding.
  • Jefferies Financial Group first reported a position in Lexicon Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Jefferies Financial Group's Lexicon Pharmaceuticals position peaked at $131K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.